Aspen Pharmacare Shares Outstanding 2017-2023 | APNHY

Aspen Pharmacare shares outstanding history from 2017 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Aspen Pharmacare shares outstanding for the quarter ending June 30, 2023 were M, a NAN% increase year-over-year.
  • Aspen Pharmacare 2023 shares outstanding were 0.444B, a 1.94% decline from 2022.
  • Aspen Pharmacare 2022 shares outstanding were 0.453B, a 0.77% decline from 2021.
  • Aspen Pharmacare 2021 shares outstanding were 0.457B, a 0% decline from 2020.
Aspen Pharmacare Annual Shares Outstanding
(Millions of Shares)
2023 444
2022 453
2021 457
2020 457
2019 457
2018 457
2017 456
2016 457
2015
Aspen Pharmacare Quarterly Shares Outstanding
(Millions of Shares)
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2016-06-30
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.038B $2.296B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.855B 5.36
Dr Reddy's Laboratories (RDY) India $12.352B 19.53
BridgeBio Pharma (BBIO) United States $4.278B 0.00
Bausch Health Cos (BHC) Canada $3.150B 2.46
Amphastar Pharmaceuticals (AMPH) United States $1.995B 13.66
Supernus Pharmaceuticals (SUPN) United States $1.604B 0.00
Taysha Gene Therapies (TSHA) United States $0.430B 0.00
Generation Bio (GBIO) United States $0.200B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.063B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00